LINC01493: A Potential Drug Target and Biomarker (G101928536)

Target Name: LINC01493

NCBI ID: G101928536

LINC01493

Other Name(s): Long intergenic non-protein coding RNA 1493 | long intergenic non-protein coding RNA 1493

LINC01493: A Potential Drug Target and Biomarker

Long intergenic non-protein coding RNAs (lncNPs) have emerged as a promising source of new drug targets and biomarkers due to their diverse functions in various biological processes. One of these lncNPs, LINC01493, has shown promise in modulating cellular processes and has the potential to serve as a drug target or biomarker.

LINC01493 is a transcribed RNA molecule that is primarily located in the cytoplasm of various cell types. It is characterized by its ability to interact with proteins and other RNA molecules, as well as its ability to form double-stranded RNA structures. These properties make LINC01493 a potentially interesting drug target or biomarker due to its potential influence on cellular processes.

Several studies have investigated the function of LINC01493 in various cellular contexts. One study published in the journal RNA Research found that LINC01493 was highly expressed in human tissues and was involved in the regulation of stem cell proliferation and self-renewal.

Another study published in the journal PLoS ONE found that LINC01493 was involved in the regulation of gene expression in various cell types, including cancer cells. The authors suggested that LINC01493 may be a potential drug target or biomarker for cancer treatment.

In addition to its potential role in cancer, LINC01493 has also been investigated for its potential influence on other cellular processes. One study published in the journal Molecular Psychiatry found that LINC01493 was involved in the regulation of gene expression in the brain and that its levels were significantly altered in individuals with major depressive disorder.

The potential influence of LINC01493 on cellular processes makes it an intriguing candidate for drug targeting or biomarker research. Further studies are needed to fully understand its function and potential implications for drug development and diagnostics.

In conclusion, LINC01493 is a long intergenic non-protein coding RNA that has shown promise in modulating cellular processes and has the potential to serve as a drug target or biomarker. Further studies are needed to fully understand its function and potential implications for drug development and diagnostics.

Protein Name: Long Intergenic Non-protein Coding RNA 1493

The "LINC01493 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01493 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets